Effectiveness and safety of the combination of fluconazole and secnidazole for the treatment of symptomatic vaginal discharge. Bogotá, Colombia

Objectives: To describe the safety and the clinical and microbiological efficacy of a single oral dose of a combined treatment with secnidazole plus fluconazole for the syndromic management of symptomatic vaginal discharge. Materials and methods: A clinical trial without control group study was co...

Full description

Bibliographic Details
Main Authors: Edith Ángel-Müller, Jorge Andrés Rubio-Romero, Andrea Rodríguez-Hernández, Ariel Ruiz-Parra
Format: Article
Language:English
Published: Federación Colombiana de Obstetricia y Ginecología 2014-03-01
Series:Revista Colombiana de Obstetricia y Ginecología
Online Access:http://revista.fecolsog.org/index.php/rcog/article/view/77
id doaj-27a10bf5b53a4fe18d24b26b12964ab9
record_format Article
spelling doaj-27a10bf5b53a4fe18d24b26b12964ab92020-11-25T02:34:56ZengFederación Colombiana de Obstetricia y GinecologíaRevista Colombiana de Obstetricia y Ginecología0034-74342463-02252014-03-0165110.18597/rcog.77Effectiveness and safety of the combination of fluconazole and secnidazole for the treatment of symptomatic vaginal discharge. Bogotá, ColombiaEdith Ángel-MüllerJorge Andrés Rubio-RomeroAndrea Rodríguez-HernándezAriel Ruiz-Parra Objectives: To describe the safety and the clinical and microbiological efficacy of a single oral dose of a combined treatment with secnidazole plus fluconazole for the syndromic management of symptomatic vaginal discharge. Materials and methods: A clinical trial without control group study was conducted including women with symptomatic vaginal discharge who assisted to a secondary level hospital in Bogota, Colombia. 118 women were included in a consecutive convenience sample who received the study treatment according to syndromic diagnosis approach. Microbiological diagnosis of bacterial vaginosis (BV) was confirmed by Nugent score, yeast infection by candida culture and trichomoniasis by wet mount. Prevalence, clinical and microbioogical efficacy and safety of the secnidazole and fluconazole combination pill was determined and a sensitivity analysis for treatment efficacy was performed. Results: The following infections were found: BV in 57.1%, candidiasis in 28.8%, and mixed infections in 10.8%. In 8.5% of the patients, the microbiology tests were negative. No trichomonas were found. The clinical cure rate was 90.4%, and the microbiological cure rate was 94.1% with the study medication. Twelve cases (12.90%) presented drug-related non serious adverse events. Conclusion: The most prevalent infection was BV, followed by candidiasis and mixed infection. The combination of a single dose of secnidazole plus fluconazole combined pill had an efficacy rate over 90% and was safe for the treatment of symptomatic women with vaginal discharge. http://revista.fecolsog.org/index.php/rcog/article/view/77
collection DOAJ
language English
format Article
sources DOAJ
author Edith Ángel-Müller
Jorge Andrés Rubio-Romero
Andrea Rodríguez-Hernández
Ariel Ruiz-Parra
spellingShingle Edith Ángel-Müller
Jorge Andrés Rubio-Romero
Andrea Rodríguez-Hernández
Ariel Ruiz-Parra
Effectiveness and safety of the combination of fluconazole and secnidazole for the treatment of symptomatic vaginal discharge. Bogotá, Colombia
Revista Colombiana de Obstetricia y Ginecología
author_facet Edith Ángel-Müller
Jorge Andrés Rubio-Romero
Andrea Rodríguez-Hernández
Ariel Ruiz-Parra
author_sort Edith Ángel-Müller
title Effectiveness and safety of the combination of fluconazole and secnidazole for the treatment of symptomatic vaginal discharge. Bogotá, Colombia
title_short Effectiveness and safety of the combination of fluconazole and secnidazole for the treatment of symptomatic vaginal discharge. Bogotá, Colombia
title_full Effectiveness and safety of the combination of fluconazole and secnidazole for the treatment of symptomatic vaginal discharge. Bogotá, Colombia
title_fullStr Effectiveness and safety of the combination of fluconazole and secnidazole for the treatment of symptomatic vaginal discharge. Bogotá, Colombia
title_full_unstemmed Effectiveness and safety of the combination of fluconazole and secnidazole for the treatment of symptomatic vaginal discharge. Bogotá, Colombia
title_sort effectiveness and safety of the combination of fluconazole and secnidazole for the treatment of symptomatic vaginal discharge. bogotá, colombia
publisher Federación Colombiana de Obstetricia y Ginecología
series Revista Colombiana de Obstetricia y Ginecología
issn 0034-7434
2463-0225
publishDate 2014-03-01
description Objectives: To describe the safety and the clinical and microbiological efficacy of a single oral dose of a combined treatment with secnidazole plus fluconazole for the syndromic management of symptomatic vaginal discharge. Materials and methods: A clinical trial without control group study was conducted including women with symptomatic vaginal discharge who assisted to a secondary level hospital in Bogota, Colombia. 118 women were included in a consecutive convenience sample who received the study treatment according to syndromic diagnosis approach. Microbiological diagnosis of bacterial vaginosis (BV) was confirmed by Nugent score, yeast infection by candida culture and trichomoniasis by wet mount. Prevalence, clinical and microbioogical efficacy and safety of the secnidazole and fluconazole combination pill was determined and a sensitivity analysis for treatment efficacy was performed. Results: The following infections were found: BV in 57.1%, candidiasis in 28.8%, and mixed infections in 10.8%. In 8.5% of the patients, the microbiology tests were negative. No trichomonas were found. The clinical cure rate was 90.4%, and the microbiological cure rate was 94.1% with the study medication. Twelve cases (12.90%) presented drug-related non serious adverse events. Conclusion: The most prevalent infection was BV, followed by candidiasis and mixed infection. The combination of a single dose of secnidazole plus fluconazole combined pill had an efficacy rate over 90% and was safe for the treatment of symptomatic women with vaginal discharge.
url http://revista.fecolsog.org/index.php/rcog/article/view/77
work_keys_str_mv AT edithangelmuller effectivenessandsafetyofthecombinationoffluconazoleandsecnidazoleforthetreatmentofsymptomaticvaginaldischargebogotacolombia
AT jorgeandresrubioromero effectivenessandsafetyofthecombinationoffluconazoleandsecnidazoleforthetreatmentofsymptomaticvaginaldischargebogotacolombia
AT andrearodriguezhernandez effectivenessandsafetyofthecombinationoffluconazoleandsecnidazoleforthetreatmentofsymptomaticvaginaldischargebogotacolombia
AT arielruizparra effectivenessandsafetyofthecombinationoffluconazoleandsecnidazoleforthetreatmentofsymptomaticvaginaldischargebogotacolombia
_version_ 1724806332765175808